Impinj, Inc. PI 深 沪
交易中 04-01 10:45:04 美东时间
102.565
-0.135
-0.13%
华盛通- 最 高107.94
- 今 开104.30
- 成交量 6.13万股
- 最 低 102.565
- 昨 收 102.70
- 总市值 31.01亿
- 52周最高 247.0635
- 市盈率 静 --
- 换手率 0.20%
- 52周最低 62.935
- 委 比 -96.85%
- 总股本 3023.17万
- 历史最高 247.0635
- 量 比 1.06
- 振 幅 5.23%
- 历史最低 9.95
- 每 手 1
- 风险率 40.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics March 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Alnylam Pharmaceuticals, Cogent Biosciences and Summit Therapeutics on Monday
03-16 18:00
Shares of semiconductor companies are trading lower amid overall market weakness due to the ongoing conflict in the Middle East. The industry may be pulling back due to high energy costs that may disrupt the chipmaking process.
Shares of semiconductor companies are trading lower amid overall market weaknes...
03-12 23:53
What's Going On With Biohaven Stock On Monday?
Biohaven shares rose in premarket trading after Xenon's Phase 3 epilepsy study showed strong seizure reduction results.
03-09 23:47
美股周涨跌榜 | DAWN周涨一倍，获国际制药集团Servier溢价收购；Ziff Davis周涨56.3%
DAWN周涨一倍，获国际制药集团Servier溢价收购；Ziff Davis周涨56.3%，将其下属部门出售给埃森哲，获巴克莱上调其目标价；TNGX周涨52.1%，Q4亏损同比收窄超预期>>
03-07 10:50
Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients
Eli Lilly's lung cancer trial shows lower recurrence risk and strong survival benefit in early-stage patients.
02-17 19:42
Small And Mid-Cap Semiconductor Stocks With Elevated P/S Ratios And Negative Ratings
As AI disruption hits several sectors, below is a list of small- and mid-cap semiconductor stocks that carry Strong Sell or Sell recommendations under the Quant Rating system and are ranked by their p...
02-14 04:21
Impinj meldet für das Gesamtjahr 2024 einen Nettoertrag von 40,84 Mio. USD, eine Veränderung um das 1,94-Fache
Impinj meldet für das Gesamtjahr 2024 einen Nettoertrag von 40,84 Mio. USD, eine Veränderung um das 1,94-Fache Impinj Inc. hat die Finanzergebnisse für das Gesamtjahr (FY) zum 31. Dezember 2025 veröffentlicht. Der Umsatz belief sich auf 361,08 Mio. USD. Das Unternehmen erzielte einen Bruttogewinn vo
02-10 05:17
Impinj posts FY2025 net loss of USD 10.85 million, reversing from prior year's profit
Impinj posts FY2025 net loss of USD 10.85 million, reversing from prior year's profit Impinj Inc. reported its full year (FY) 2025 financial results, posting revenue of USD 361.08 million. Gross profit for the period reached USD 189.68 million. Research and development expenses totaled USD 102.62 mi
02-10 05:17
美股大行评级 | 遭多家大行下调目标价！亚马逊、Affirm、Roblox、汤森路透、Doximity、OneMain、Atlassian、Peloton等等
今日重点评级关注：HC Wainwright & Co.：维持NovaBridge Biosciences"买入"评级，目标价从7美元升至9美元；Truist Securities：维持Reddit"买入"评级，目标价从270美元升至275美元
02-09 14:37
